chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Aortic dissection, Computerised tomogram, Laboratory test
Clinical narrative: My aorta dissected; This is a spontaneous report from a contactable consumer (patient). A 40-year-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration administered on arm right on 03Mar2021 (Batch/Lot Number: EN6198) as SINGLE DOSE for COVID-19 immunization at urgent Care Center.  Medical history included Marfan's syndrome. Concomitant medications included metoprolol tartrate (METOPROLOL TARTRATE), enalaprilat (ENALAPRILAT) and warfarin sodium (COUMADIN) all taken for an unspecified indications and therapy dates. On 07Mar2021 17:45, the patient had aorta disorder (reported as aorta was dissected) which requires emergency room/department or urgent care visit. The patient was hospitalized in 2021 for 11 days. The event was also considered as life threatening illness (immediate risk of death from the event). The patient also had received unspecified medication. The patient had nasal swab on 02Apr2021 which showed negative. Outcome of the event was not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Aortic disorder, SARS-CoV-2 test
Clinical narrative: My aorta dissected; This is a spontaneous report from a contactable consumer (patient). A 40-year-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration administered on arm right on 03Mar2021 (Batch/Lot Number: EN6198) as SINGLE DOSE for COVID-19 immunization at urgent Care Center.  Medical history included Marfan's syndrome. Concomitant medications included metoprolol tartrate (METOPROLOL TARTRATE), enalaprilat (ENALAPRILAT) and warfarin sodium (COUMADIN) all taken for an unspecified indications and therapy dates. On 07Mar2021 17:45, the patient had aorta disorder (reported as aorta was dissected) which requires emergency room/department or urgent care visit. The patient was hospitalized in 2021 for 11 days. The event was also considered as life threatening illness (immediate risk of death from the event). The patient also had received unspecified medication. The patient had nasal swab on 02Apr2021 which showed negative. Outcome of the event was not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain upper, Appendicectomy, Appendicitis, Appendicitis perforated, Blood test abnormal
Clinical narrative: I was diagnosed with Appendicitis on 31Mar; This is a spontaneous report from a contactable consumer (patient). A 34-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration at the age of 34 years old, administered in arm left on 24Mar2021 13:00 (Lot Number: EP7534) as single dose for covid-19 immunisation. Medical history included type 1 diabetes mellitus, obesity. Concomitant medications included insulin lispro (HUMALOG); insulin glargine (LANTUS). The patient previously took erythromycin and experienced allergies: erythromycin. The patient was diagnosed with appendicitis on 30Mar2021 07:00. Event resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, hospitalization, life threatening illness (immediate risk of death from the event). The patient was hospitalized for appendicitis for 2 days and received appendectomy as treatment. The patient underwent lab tests and procedures which included COVID-19 virus test (Nasal Swab): negative on 31Mar2021. The outcome of the event was recovering. Prior to vaccination, the patient was not diagnosed with COVID-19.
Age: 34.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram abdomen abnormal, Surgery
Clinical narrative: I was diagnosed with Appendicitis on 31Mar; This is a spontaneous report from a contactable consumer (patient). A 34-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration at the age of 34 years old, administered in arm left on 24Mar2021 13:00 (Lot Number: EP7534) as single dose for covid-19 immunisation. Medical history included type 1 diabetes mellitus, obesity. Concomitant medications included insulin lispro (HUMALOG); insulin glargine (LANTUS). The patient previously took erythromycin and experienced allergies: erythromycin. The patient was diagnosed with appendicitis on 30Mar2021 07:00. Event resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, hospitalization, life threatening illness (immediate risk of death from the event). The patient was hospitalized for appendicitis for 2 days and received appendectomy as treatment. The patient underwent lab tests and procedures which included COVID-19 virus test (Nasal Swab): negative on 31Mar2021. The outcome of the event was recovering. Prior to vaccination, the patient was not diagnosed with COVID-19.
Age: 34.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Appendicitis, SARS-CoV-2 test
Clinical narrative: I was diagnosed with Appendicitis on 31Mar; This is a spontaneous report from a contactable consumer (patient). A 34-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration at the age of 34 years old, administered in arm left on 24Mar2021 13:00 (Lot Number: EP7534) as single dose for covid-19 immunisation. Medical history included type 1 diabetes mellitus, obesity. Concomitant medications included insulin lispro (HUMALOG); insulin glargine (LANTUS). The patient previously took erythromycin and experienced allergies: erythromycin. The patient was diagnosed with appendicitis on 30Mar2021 07:00. Event resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, hospitalization, life threatening illness (immediate risk of death from the event). The patient was hospitalized for appendicitis for 2 days and received appendectomy as treatment. The patient underwent lab tests and procedures which included COVID-19 virus test (Nasal Swab): negative on 31Mar2021. The outcome of the event was recovering. Prior to vaccination, the patient was not diagnosed with COVID-19.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Back pain, Death, Fatigue, Musculoskeletal discomfort
Clinical narrative: BLOOD CLOT; HEART ATTACK; This spontaneous report received from a health care professional (nurse) concerned a 67 year old female. The patient's weight and height were not reported. the patient's past medical history included blood clot, and heart attack. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown, expiry-unknown) dose was not reported, 1 total administered on 08-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date in MAR-2021, the patient experienced blood clot/heart attack. On 26-MAR-2021 the patient died from blood clot, and heart attack. It was unspecified if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of blood clot and heart attack was fatal. This report was serious (Death).; Sender's Comments: V0: This 67 year-old female with history of blood clot and heart attack experienced fatal blood clot and heart attack 18 days after receiving the Janssen Covid-19 vaccine, No further information regarding medical history, concomitant medications, social history, diagnostic test results, or other data was available. It is unknown if an autopsy was performed. Based on the limited information which includes past history of blood clot and heart attack, the fatal events are inconsistent with the causal association to immunization, per the WHO causality classification for adverse events following immunization.  Additional information is being sought.; Reported Cause(s) of Death: BLOOD CLOT; HEART ATTACK
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Myocardial infarction, Thrombosis
Clinical narrative: BLOOD CLOT; HEART ATTACK; This spontaneous report received from a health care professional (nurse) concerned a 67 year old female. The patient's weight and height were not reported. the patient's past medical history included blood clot, and heart attack. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown, expiry-unknown) dose was not reported, 1 total administered on 08-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date in MAR-2021, the patient experienced blood clot/heart attack. On 26-MAR-2021 the patient died from blood clot, and heart attack. It was unspecified if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of blood clot and heart attack was fatal. This report was serious (Death).; Sender's Comments: V0: This 67 year-old female with history of blood clot and heart attack experienced fatal blood clot and heart attack 18 days after receiving the Janssen Covid-19 vaccine, No further information regarding medical history, concomitant medications, social history, diagnostic test results, or other data was available. It is unknown if an autopsy was performed. Based on the limited information which includes past history of blood clot and heart attack, the fatal events are inconsistent with the causal association to immunization, per the WHO causality classification for adverse events following immunization.  Additional information is being sought.; Reported Cause(s) of Death: BLOOD CLOT; HEART ATTACK
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Activated partial thromboplastin time shortened, Alanine aminotransferase increased, Angiogram pulmonary abnormal, Aspartate aminotransferase increased, Blood alkaline phosphatase decreased
Clinical narrative: Cavernous Sinus Thrombosis, Right Jugular Thrombosis, Pulmonary Embolism, thrombocytopenia (20K)
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Blood electrolytes normal, Cerebral venous sinus thrombosis, Dizziness, Haptoglobin normal, Headache
Clinical narrative: Cavernous Sinus Thrombosis, Right Jugular Thrombosis, Pulmonary Embolism, thrombocytopenia (20K)
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Platelet count decreased, Pulmonary embolism, Rash erythematous, Thrombin time prolonged, Ultrasound scan normal
Clinical narrative: Cavernous Sinus Thrombosis, Right Jugular Thrombosis, Pulmonary Embolism, thrombocytopenia (20K)
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Venogram abnormal
Clinical narrative: Cavernous Sinus Thrombosis, Right Jugular Thrombosis, Pulmonary Embolism, thrombocytopenia (20K)
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Cerebral venous sinus thrombosis, Heparin-induced thrombocytopenia test, Immunology test, Platelet factor 4, Pulmonary embolism
Clinical narrative: Cavernous Sinus Thrombosis, Right Jugular Thrombosis, Pulmonary Embolism, thrombocytopenia (20K)
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Activated partial thromboplastin time, Activated partial thromboplastin time prolonged, Activated partial thromboplastin time shortened, Alanine aminotransferase, Alanine aminotransferase increased
Clinical narrative: Cavernous Sinus Thrombosis, Right Jugular Thrombosis, Pulmonary Embolism, thrombocytopenia (20K)
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Angiogram, Angiogram pulmonary, Angiogram pulmonary abnormal, Aspartate aminotransferase, Aspartate aminotransferase increased
Clinical narrative: Cavernous Sinus Thrombosis, Right Jugular Thrombosis, Pulmonary Embolism, thrombocytopenia (20K)
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Blood alkaline phosphatase, Blood alkaline phosphatase decreased, Blood electrolytes, Blood electrolytes normal, Blood fibrinogen
Clinical narrative: Cavernous Sinus Thrombosis, Right Jugular Thrombosis, Pulmonary Embolism, thrombocytopenia (20K)
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Blood pressure measurement, Blood test, Cerebral venous sinus thrombosis, Dizziness, Fibrin D dimer
Clinical narrative: Cavernous Sinus Thrombosis, Right Jugular Thrombosis, Pulmonary Embolism, thrombocytopenia (20K)
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Haemoglobin, Haptoglobin, Haptoglobin normal, Headache, Immunology test
Clinical narrative: Cavernous Sinus Thrombosis, Right Jugular Thrombosis, Pulmonary Embolism, thrombocytopenia (20K)
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Platelet count, Platelet count decreased, Platelet factor 4, Pulmonary embolism, Rash erythematous
Clinical narrative: Cavernous Sinus Thrombosis, Right Jugular Thrombosis, Pulmonary Embolism, thrombocytopenia (20K)
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test negative, Thrombin time, Thrombin time prolonged, Transaminases increased, Ultrasound scan
Clinical narrative: Cavernous Sinus Thrombosis, Right Jugular Thrombosis, Pulmonary Embolism, thrombocytopenia (20K)
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Ultrasound scan normal, Venogram, Venogram abnormal
Clinical narrative: Cavernous Sinus Thrombosis, Right Jugular Thrombosis, Pulmonary Embolism, thrombocytopenia (20K)
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Cavernous sinus thrombosis, Computerised tomogram abnormal, Computerised tomogram head abnormal, Computerised tomogram neck, Computerised tomogram thorax abnormal
Clinical narrative: Cavernous Sinus Thrombosis, Right Jugular Thrombosis, Pulmonary Embolism, thrombocytopenia (20K)
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Jugular vein thrombosis, Laboratory test abnormal, Pulmonary embolism, Thrombocytopenia
Clinical narrative: Cavernous Sinus Thrombosis, Right Jugular Thrombosis, Pulmonary Embolism, thrombocytopenia (20K)
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Pain in extremity, Seizure like phenomena
Clinical narrative: Posterior headache, shooting leg pain, short of air, myalgias, muscle spasms, sensativity to touch, decreased energy
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Dyspnoea, Full blood count normal, Headache, Hyperaesthesia
Clinical narrative: Posterior headache, shooting leg pain, short of air, myalgias, muscle spasms, sensativity to touch, decreased energy
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Muscle spasms, Myalgia, Neutrophil count decreased, Pain in extremity, Platelet count increased
Clinical narrative: Posterior headache, shooting leg pain, short of air, myalgias, muscle spasms, sensativity to touch, decreased energy
Age: 23.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Antinuclear antibody, Blood thyroid stimulating hormone normal, C-reactive protein increased, Coagulation test, Deep vein thrombosis
Clinical narrative: approximately 1 week after the first dose I began to have red, painful nodules of both forearms; approximately 1 week after the first dose I began to have red, painful nodules of both forearms; This is a spontaneous report from a contactable consumer (patient). A 23-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EL0142), first dose via an unspecified route of administration, administered in Arm Left on 04Jan2021 11:30, single dose covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Approximately 1 week after the first dose (12Jan2021) at 12:30 patient began to have red, painful nodules of both forearms not just the left arm, he received the vaccine in. At this time, he was advised and took Benadryl for around 10 days. This appeared to alleviate the symptoms as the nodules went away.  The adverse events resulted in visit to doctor. The events were assessed as life threatening. The outcome of the events was not recovered. Treatment of Eliquis was initiated yesterday.  No COVID prior vaccination. Not COVID tested post vaccination. No Known allergies.
Age: 23.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Fibrin D dimer, Full blood count normal, Injection site nodule, Injection site rash, Metabolic function test normal
Clinical narrative: approximately 1 week after the first dose I began to have red, painful nodules of both forearms; approximately 1 week after the first dose I began to have red, painful nodules of both forearms; This is a spontaneous report from a contactable consumer (patient). A 23-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EL0142), first dose via an unspecified route of administration, administered in Arm Left on 04Jan2021 11:30, single dose covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Approximately 1 week after the first dose (12Jan2021) at 12:30 patient began to have red, painful nodules of both forearms not just the left arm, he received the vaccine in. At this time, he was advised and took Benadryl for around 10 days. This appeared to alleviate the symptoms as the nodules went away.  The adverse events resulted in visit to doctor. The events were assessed as life threatening. The outcome of the events was not recovered. Treatment of Eliquis was initiated yesterday.  No COVID prior vaccination. Not COVID tested post vaccination. No Known allergies.
Age: 23.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pain in extremity, Rash, Rash erythematous, Red blood cell sedimentation rate normal, Thrombophlebitis superficial
Clinical narrative: approximately 1 week after the first dose I began to have red, painful nodules of both forearms; approximately 1 week after the first dose I began to have red, painful nodules of both forearms; This is a spontaneous report from a contactable consumer (patient). A 23-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EL0142), first dose via an unspecified route of administration, administered in Arm Left on 04Jan2021 11:30, single dose covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Approximately 1 week after the first dose (12Jan2021) at 12:30 patient began to have red, painful nodules of both forearms not just the left arm, he received the vaccine in. At this time, he was advised and took Benadryl for around 10 days. This appeared to alleviate the symptoms as the nodules went away.  The adverse events resulted in visit to doctor. The events were assessed as life threatening. The outcome of the events was not recovered. Treatment of Eliquis was initiated yesterday.  No COVID prior vaccination. Not COVID tested post vaccination. No Known allergies.
Age: 23.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Thrombosis, Ultrasound Doppler abnormal, Varicose vein
Clinical narrative: approximately 1 week after the first dose I began to have red, painful nodules of both forearms; approximately 1 week after the first dose I began to have red, painful nodules of both forearms; This is a spontaneous report from a contactable consumer (patient). A 23-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EL0142), first dose via an unspecified route of administration, administered in Arm Left on 04Jan2021 11:30, single dose covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Approximately 1 week after the first dose (12Jan2021) at 12:30 patient began to have red, painful nodules of both forearms not just the left arm, he received the vaccine in. At this time, he was advised and took Benadryl for around 10 days. This appeared to alleviate the symptoms as the nodules went away.  The adverse events resulted in visit to doctor. The events were assessed as life threatening. The outcome of the events was not recovered. Treatment of Eliquis was initiated yesterday.  No COVID prior vaccination. Not COVID tested post vaccination. No Known allergies.
Age: 23.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Nodule, Pain in extremity
Clinical narrative: approximately 1 week after the first dose I began to have red, painful nodules of both forearms; approximately 1 week after the first dose I began to have red, painful nodules of both forearms; This is a spontaneous report from a contactable consumer (patient). A 23-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EL0142), first dose via an unspecified route of administration, administered in Arm Left on 04Jan2021 11:30, single dose covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Approximately 1 week after the first dose (12Jan2021) at 12:30 patient began to have red, painful nodules of both forearms not just the left arm, he received the vaccine in. At this time, he was advised and took Benadryl for around 10 days. This appeared to alleviate the symptoms as the nodules went away.  The adverse events resulted in visit to doctor. The events were assessed as life threatening. The outcome of the events was not recovered. Treatment of Eliquis was initiated yesterday.  No COVID prior vaccination. Not COVID tested post vaccination. No Known allergies.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Fibrin D dimer, Magnetic resonance imaging, Ultrasound scan, Venous thrombosis limb
Clinical narrative: BLOOD CLOT IN LEG; BLOOD CLOT IN LUNG; This spontaneous self-report was received from a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805029, expiry: unspecified) dose and therapy start date were not reported for prophylactic vaccination. No concomitant medications were reported.  On an unspecified date, 2 weeks after getting vaccination, the patient experienced blood clot in leg and blood clot in lung. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the thrombosis leg and thrombosis pulmonary was not reported. The patient also reported to VAERS (no reference number provided). This report was serious (Other Medically Important Condition).; Sender's Comments: A patient of unspecified age and sex experienced thrombosis leg and thrombosis pulmonary 2 weeks after vaccine. No concomitant medications were reported. No additional history, diagnostics, treatment, or other information was reported. There is insufficient information to make a meaningful medical assessment. Additional information has been requested.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Pulmonary thrombosis, Thrombosis
Clinical narrative: BLOOD CLOT IN LEG; BLOOD CLOT IN LUNG; This spontaneous self-report was received from a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805029, expiry: unspecified) dose and therapy start date were not reported for prophylactic vaccination. No concomitant medications were reported.  On an unspecified date, 2 weeks after getting vaccination, the patient experienced blood clot in leg and blood clot in lung. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the thrombosis leg and thrombosis pulmonary was not reported. The patient also reported to VAERS (no reference number provided). This report was serious (Other Medically Important Condition).; Sender's Comments: A patient of unspecified age and sex experienced thrombosis leg and thrombosis pulmonary 2 weeks after vaccine. No concomitant medications were reported. No additional history, diagnostics, treatment, or other information was reported. There is insufficient information to make a meaningful medical assessment. Additional information has been requested.
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest X-ray normal, Chills, Cough, Dyspnoea, Erythema
Clinical narrative: 3/17/21 - Covid 19 vaccine. 3/18 - Arm pain with road rash. resolved after 4 days. 3/19 - worked - run down. that night shiver, T102 x2d. 3/20 - started to cough, work by 3/23 - SOB, Albuterol x 4, Advair, started prednisone 40mg. - after 3 days - Sl. worse. Pt couldn't work. cough, exhausted. CXR 4/8 - 3/25 covid - 4/9 - not better -> tx'd Azithromycin  4/13 - hot, freezing. exhausted. still couldn't work SOB, cough. 4/13 visit - R ankle swollen with rash initially finger tip size -> 3/4 LE above ankle 4/15 - called. couldn't stop coughing.  Rx'd prednisone 60mg x 5d -> taper
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Headache, Limb discomfort, Pain, Pyrexia, Rash macular
Clinical narrative: 3/17/21 - Covid 19 vaccine. 3/18 - Arm pain with road rash. resolved after 4 days. 3/19 - worked - run down. that night shiver, T102 x2d. 3/20 - started to cough, work by 3/23 - SOB, Albuterol x 4, Advair, started prednisone 40mg. - after 3 days - Sl. worse. Pt couldn't work. cough, exhausted. CXR 4/8 - 3/25 covid - 4/9 - not better -> tx'd Azithromycin  4/13 - hot, freezing. exhausted. still couldn't work SOB, cough. 4/13 visit - R ankle swollen with rash initially finger tip size -> 3/4 LE above ankle 4/15 - called. couldn't stop coughing.  Rx'd prednisone 60mg x 5d -> taper
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Chest X-ray, Chills, Cough, Dyspnoea
Clinical narrative: 3/17/21 - Covid 19 vaccine. 3/18 - Arm pain with road rash. resolved after 4 days. 3/19 - worked - run down. that night shiver, T102 x2d. 3/20 - started to cough, work by 3/23 - SOB, Albuterol x 4, Advair, started prednisone 40mg. - after 3 days - Sl. worse. Pt couldn't work. cough, exhausted. CXR 4/8 - 3/25 covid - 4/9 - not better -> tx'd Azithromycin  4/13 - hot, freezing. exhausted. still couldn't work SOB, cough. 4/13 visit - R ankle swollen with rash initially finger tip size -> 3/4 LE above ankle 4/15 - called. couldn't stop coughing.  Rx'd prednisone 60mg x 5d -> taper
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Feeling abnormal, Feeling of body temperature change, Impaired work ability, Joint swelling
Clinical narrative: 3/17/21 - Covid 19 vaccine. 3/18 - Arm pain with road rash. resolved after 4 days. 3/19 - worked - run down. that night shiver, T102 x2d. 3/20 - started to cough, work by 3/23 - SOB, Albuterol x 4, Advair, started prednisone 40mg. - after 3 days - Sl. worse. Pt couldn't work. cough, exhausted. CXR 4/8 - 3/25 covid - 4/9 - not better -> tx'd Azithromycin  4/13 - hot, freezing. exhausted. still couldn't work SOB, cough. 4/13 visit - R ankle swollen with rash initially finger tip size -> 3/4 LE above ankle 4/15 - called. couldn't stop coughing.  Rx'd prednisone 60mg x 5d -> taper
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Rash
Clinical narrative: 3/17/21 - Covid 19 vaccine. 3/18 - Arm pain with road rash. resolved after 4 days. 3/19 - worked - run down. that night shiver, T102 x2d. 3/20 - started to cough, work by 3/23 - SOB, Albuterol x 4, Advair, started prednisone 40mg. - after 3 days - Sl. worse. Pt couldn't work. cough, exhausted. CXR 4/8 - 3/25 covid - 4/9 - not better -> tx'd Azithromycin  4/13 - hot, freezing. exhausted. still couldn't work SOB, cough. 4/13 visit - R ankle swollen with rash initially finger tip size -> 3/4 LE above ankle 4/15 - called. couldn't stop coughing.  Rx'd prednisone 60mg x 5d -> taper
Age: 28.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Deep vein thrombosis, Ultrasound scan abnormal
Clinical narrative: Blood Clot diagnosed at  Hospital.
Age: 28.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Thrombosis
Clinical narrative: Blood Clot diagnosed at  Hospital.
Age: 45.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Abdominal pain, Chest pain, Dyspnoea exertional, Electrocardiogram, Fibrin D dimer
Clinical narrative: Pt presented to the ER at our facility complaining of chest pain. Was found to have bilateral segmental PE.
Age: 45.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Musculoskeletal chest pain
Clinical narrative: Pt presented to the ER at our facility complaining of chest pain. Was found to have bilateral segmental PE.
Age: 45.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Chest X-ray abnormal, Chest pain, Dyspnoea, Electrocardiogram, Fibrin D dimer
Clinical narrative: Pt presented to the ER at our facility complaining of chest pain. Was found to have bilateral segmental PE.
Age: 45.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Pulmonary oedema
Clinical narrative: Pt presented to the ER at our facility complaining of chest pain. Was found to have bilateral segmental PE.
Age: 45.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Pulmonary embolism
Clinical narrative: Pt presented to the ER at our facility complaining of chest pain. Was found to have bilateral segmental PE.
Age: 45.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Chest pain, Pulmonary embolism
Clinical narrative: Pt presented to the ER at our facility complaining of chest pain. Was found to have bilateral segmental PE.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Thrombophlebitis superficial
Clinical narrative: About a week after the vaccine my granddaughter noticed a bruise on my leg.  The next day I went to the ER who did an ultrasound and confirmed it was a blood clot.  I was given 2 pill of Eloquis but I only took 1 and was released.  Shortly after I noticed my mouth and tongue was feeling heavy so I returned back to the ER but by that time I couldn't speak.  I began having bouts of experiences like seizures and my body was frozen which caused them to admit me into the hospital.  I was given Coumidin at that time and monitored but before the 20 minutes had expired I again could no longer speak and began having the seizure episodes again so I was transported to have a MRI because they felt I was having a stroke.  I was administered benedryl at that time.  The next day 5mg of Warfarin was given and shortly after taking it while on the phone I begin to loose my speech again but I couldnt move or speak to call for the nurse and my sister who was on the line had to hang up and call out to the front desk to get me assistance.  I was given another MRI because they felt it was another stroke and was transported back to my room for monitoring.  I am now receiving an IV Fondaparinux (Intrexor) about 4 times a day for the clotting but my INR  levels still wont rise pass 1.0
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Aphasia, Cerebrovascular accident, Contusion, International normalised ratio normal, Magnetic resonance imaging head
Clinical narrative: About a week after the vaccine my granddaughter noticed a bruise on my leg.  The next day I went to the ER who did an ultrasound and confirmed it was a blood clot.  I was given 2 pill of Eloquis but I only took 1 and was released.  Shortly after I noticed my mouth and tongue was feeling heavy so I returned back to the ER but by that time I couldn't speak.  I began having bouts of experiences like seizures and my body was frozen which caused them to admit me into the hospital.  I was given Coumidin at that time and monitored but before the 20 minutes had expired I again could no longer speak and began having the seizure episodes again so I was transported to have a MRI because they felt I was having a stroke.  I was administered benedryl at that time.  The next day 5mg of Warfarin was given and shortly after taking it while on the phone I begin to loose my speech again but I couldnt move or speak to call for the nurse and my sister who was on the line had to hang up and call out to the front desk to get me assistance.  I was given another MRI because they felt it was another stroke and was transported back to my room for monitoring.  I am now receiving an IV Fondaparinux (Intrexor) about 4 times a day for the clotting but my INR  levels still wont rise pass 1.0
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Movement disorder, Oral discomfort, Seizure, Seizure like phenomena, Simple partial seizures
Clinical narrative: About a week after the vaccine my granddaughter noticed a bruise on my leg.  The next day I went to the ER who did an ultrasound and confirmed it was a blood clot.  I was given 2 pill of Eloquis but I only took 1 and was released.  Shortly after I noticed my mouth and tongue was feeling heavy so I returned back to the ER but by that time I couldn't speak.  I began having bouts of experiences like seizures and my body was frozen which caused them to admit me into the hospital.  I was given Coumidin at that time and monitored but before the 20 minutes had expired I again could no longer speak and began having the seizure episodes again so I was transported to have a MRI because they felt I was having a stroke.  I was administered benedryl at that time.  The next day 5mg of Warfarin was given and shortly after taking it while on the phone I begin to loose my speech again but I couldnt move or speak to call for the nurse and my sister who was on the line had to hang up and call out to the front desk to get me assistance.  I was given another MRI because they felt it was another stroke and was transported back to my room for monitoring.  I am now receiving an IV Fondaparinux (Intrexor) about 4 times a day for the clotting but my INR  levels still wont rise pass 1.0
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Thrombosis, Tongue discomfort, Ultrasound Doppler abnormal
Clinical narrative: About a week after the vaccine my granddaughter noticed a bruise on my leg.  The next day I went to the ER who did an ultrasound and confirmed it was a blood clot.  I was given 2 pill of Eloquis but I only took 1 and was released.  Shortly after I noticed my mouth and tongue was feeling heavy so I returned back to the ER but by that time I couldn't speak.  I began having bouts of experiences like seizures and my body was frozen which caused them to admit me into the hospital.  I was given Coumidin at that time and monitored but before the 20 minutes had expired I again could no longer speak and began having the seizure episodes again so I was transported to have a MRI because they felt I was having a stroke.  I was administered benedryl at that time.  The next day 5mg of Warfarin was given and shortly after taking it while on the phone I begin to loose my speech again but I couldnt move or speak to call for the nurse and my sister who was on the line had to hang up and call out to the front desk to get me assistance.  I was given another MRI because they felt it was another stroke and was transported back to my room for monitoring.  I am now receiving an IV Fondaparinux (Intrexor) about 4 times a day for the clotting but my INR  levels still wont rise pass 1.0
Age: 18.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Adenovirus test, Anion gap normal, Antinuclear antibody positive, Bacterial test, Bacterial test negative
Clinical narrative: ED visit and hospitalization within 6 weeks of receiving first dose of COVID vaccination. Second dose not yet received.
Age: 18.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Basophil count decreased, Basophil count normal, Biopsy bone marrow normal, Blastomycosis, Blood chloride normal
Clinical narrative: ED visit and hospitalization within 6 weeks of receiving first dose of COVID vaccination. Second dose not yet received.
Age: 18.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Blood culture negative, Blood lactic acid decreased, Blood potassium normal, Blood sodium decreased, Blood urea normal
Clinical narrative: ED visit and hospitalization within 6 weeks of receiving first dose of COVID vaccination. Second dose not yet received.
Age: 18.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Bordetella test negative, C-reactive protein increased, Carbon dioxide decreased, Chromaturia, Complement factor C4
Clinical narrative: ED visit and hospitalization within 6 weeks of receiving first dose of COVID vaccination. Second dose not yet received.
Age: 18.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Cytomegalovirus test negative, Cytopenia, Double stranded DNA antibody positive, Enterovirus test negative, Eosinophil count normal
Clinical narrative: ED visit and hospitalization within 6 weeks of receiving first dose of COVID vaccination. Second dose not yet received.
Age: 18.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Epstein-Barr virus test negative, Fibrin D dimer increased, Glomerular filtration rate normal, Glucose urine absent, HIV antibody negative
Clinical narrative: ED visit and hospitalization within 6 weeks of receiving first dose of COVID vaccination. Second dose not yet received.
Age: 18.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: HIV antigen negative, HIV test negative, Haematocrit decreased, Haemoglobin decreased, Headache
Clinical narrative: ED visit and hospitalization within 6 weeks of receiving first dose of COVID vaccination. Second dose not yet received.
Age: 18.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Histoplasmosis, Human anaplasmosis, Human metapneumovirus test, Human rhinovirus test, Hypoxia
Clinical narrative: ED visit and hospitalization within 6 weeks of receiving first dose of COVID vaccination. Second dose not yet received.
Age: 18.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Influenza A virus test negative, Influenza B virus test, Lymphocyte count normal, Lymphocyte percentage increased, Mean cell haemoglobin concentration normal
Clinical narrative: ED visit and hospitalization within 6 weeks of receiving first dose of COVID vaccination. Second dose not yet received.
Age: 18.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Mean cell haemoglobin normal, Mean cell volume normal, Monocyte count decreased, Monocyte count normal, Mycoplasma test negative
Clinical narrative: ED visit and hospitalization within 6 weeks of receiving first dose of COVID vaccination. Second dose not yet received.
Age: 18.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Neutrophil count decreased, Neutrophil percentage decreased, Nitrite urine absent, Pancytopenia, Platelet count normal
Clinical narrative: ED visit and hospitalization within 6 weeks of receiving first dose of COVID vaccination. Second dose not yet received.
Age: 18.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Platelet morphology normal, Procalcitonin, Protein urine present, Pyrexia, Red blood cell count decreased
Clinical narrative: ED visit and hospitalization within 6 weeks of receiving first dose of COVID vaccination. Second dose not yet received.
Age: 18.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Red blood cell elliptocytes present, Red blood cells urine negative, Red cell distribution width normal, Respiratory syncytial virus test negative, Rheumatoid factor negative
Clinical narrative: ED visit and hospitalization within 6 weeks of receiving first dose of COVID vaccination. Second dose not yet received.
Age: 18.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Rickettsiosis, SARS-CoV-2 test negative, Specific gravity urine normal, Transaminases increased, Urinary sediment present
Clinical narrative: ED visit and hospitalization within 6 weeks of receiving first dose of COVID vaccination. Second dose not yet received.
Age: 18.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Urine abnormality, Urine ketone body absent, Urine leukocyte esterase, Urine phosphorus normal, White blood cell count decreased
Clinical narrative: ED visit and hospitalization within 6 weeks of receiving first dose of COVID vaccination. Second dose not yet received.
Age: 18.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: White blood cells urine negative
Clinical narrative: ED visit and hospitalization within 6 weeks of receiving first dose of COVID vaccination. Second dose not yet received.
Age: 18.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: ED visit and hospitalization within 6 weeks of receiving first dose of COVID vaccination. Second dose not yet received.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Angiogram, Fibrin D dimer, Full blood count, Heavy menstrual bleeding, Metabolic function test
Clinical narrative: Acute ITP - Platelet 2K on admission, previously 279K in Feb 2021 - Reports receiving J&J COVID vaccine 1 month prior - s/p 2 units platelet transfusion (4/9 and 4/10) - s/p IVIG x 4 days - Continue Prednisone taper (80mg daily for 2 more days, then 60mg daily until follows up with Hematology and repeat CBC).  - Plan to follow-up with PCP  on 4/16 and Hematology on 4/19
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Petechiae, Platelet count decreased, Troponin
Clinical narrative: Acute ITP - Platelet 2K on admission, previously 279K in Feb 2021 - Reports receiving J&J COVID vaccine 1 month prior - s/p 2 units platelet transfusion (4/9 and 4/10) - s/p IVIG x 4 days - Continue Prednisone taper (80mg daily for 2 more days, then 60mg daily until follows up with Hematology and repeat CBC).  - Plan to follow-up with PCP  on 4/16 and Hematology on 4/19
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Immune thrombocytopenia, Immunoglobulin therapy, Platelet count decreased, Platelet transfusion
Clinical narrative: Acute ITP - Platelet 2K on admission, previously 279K in Feb 2021 - Reports receiving J&J COVID vaccine 1 month prior - s/p 2 units platelet transfusion (4/9 and 4/10) - s/p IVIG x 4 days - Continue Prednisone taper (80mg daily for 2 more days, then 60mg daily until follows up with Hematology and repeat CBC).  - Plan to follow-up with PCP  on 4/16 and Hematology on 4/19
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain upper, Angiogram, Blood thyroid stimulating hormone, Dizziness, Fatigue
Clinical narrative: I received the Janssen COVAX on Monday morning, 5 Apr 2021.  A week later, on Monday evening, 12 Apr 2021, I experienced extremely painful leg cramps and broke out in a sweat. I felt extremely nauseous, and weak, this was followed by a sever pain in my head that was so extreme that I passed out. After coming to, the pain in my head finally began to subside, along with the leg cramps. My husband indicated that I was unconscious for just under a minute.  For the next two days, I had bouts of nausea, headaches, sweats, and was extremely tired.  On Wednesday, 14 Apr, after learning of the issues related to the Janssen vaccine, and the symptoms described being what I experienced, I contacted the advice (cont'd)..Additional information for Item 18: Line and was told to go to Emergency Room at the hospital, which I did.  I do not feel that they addressed my concerns or the symptoms that I was experiencing, and at no time did they try to determine if it was due to the vaccine.  The discharge papers did not even address the "event" and the "symptoms" that I described.  They did not take any information down related to the vaccine, lot number, etc., that I had received.  They seemed to go through a set routine:  blood pressure, blood work, temperature, EKG, and CAT scan.    21. (continued)...Visited Emergency Room, however, was requested by ER to go to Primary Care as follow-up, however, as a  Employee we cannot be seen by Primary Care on THIS site.  Instead , we have to go on the local clinic to receive care.  The issue is that this was a vaccine that I was scheduled by my leadership to receive, with no choice in choosing which vaccine I could receive, and without follow-up care for adverse reactions. The hospital did not indicate to me that I should report this incident, however, I am concerned as a result of the "event" that I experienced, that it should be reported.  Furthermore,we should have a choice as to which vaccine we want to receive, just as everyone does.  Your form does not allow for input addresses  Also, your form does not allow for a phone number.  I am out of the country.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Full blood count, Headache, Hyperhidrosis, Loss of consciousness, Metabolic function test
Clinical narrative: I received the Janssen COVAX on Monday morning, 5 Apr 2021.  A week later, on Monday evening, 12 Apr 2021, I experienced extremely painful leg cramps and broke out in a sweat. I felt extremely nauseous, and weak, this was followed by a sever pain in my head that was so extreme that I passed out. After coming to, the pain in my head finally began to subside, along with the leg cramps. My husband indicated that I was unconscious for just under a minute.  For the next two days, I had bouts of nausea, headaches, sweats, and was extremely tired.  On Wednesday, 14 Apr, after learning of the issues related to the Janssen vaccine, and the symptoms described being what I experienced, I contacted the advice (cont'd)..Additional information for Item 18: Line and was told to go to Emergency Room at the hospital, which I did.  I do not feel that they addressed my concerns or the symptoms that I was experiencing, and at no time did they try to determine if it was due to the vaccine.  The discharge papers did not even address the "event" and the "symptoms" that I described.  They did not take any information down related to the vaccine, lot number, etc., that I had received.  They seemed to go through a set routine:  blood pressure, blood work, temperature, EKG, and CAT scan.    21. (continued)...Visited Emergency Room, however, was requested by ER to go to Primary Care as follow-up, however, as a  Employee we cannot be seen by Primary Care on THIS site.  Instead , we have to go on the local clinic to receive care.  The issue is that this was a vaccine that I was scheduled by my leadership to receive, with no choice in choosing which vaccine I could receive, and without follow-up care for adverse reactions. The hospital did not indicate to me that I should report this incident, however, I am concerned as a result of the "event" that I experienced, that it should be reported.  Furthermore,we should have a choice as to which vaccine we want to receive, just as everyone does.  Your form does not allow for input addresses  Also, your form does not allow for a phone number.  I am out of the country.